S&P 100
3.344,90
PKT
+17,43
PKT
+0,52
%
Werbung
Analysen zu S&P 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
12.03.12 | Linde halten | Independent Research GmbH | |
12.03.12 | Chevron overweight | Barclays Capital | |
12.03.12 | Starbucks buy | Deutsche Bank Securities | |
09.03.12 | Linde add | WestLB AG | |
09.03.12 | ExxonMobil buy | UBS AG | |
09.03.12 | Starbucks buy | UBS AG | |
09.03.12 | AT&T neutral | UBS AG | |
09.03.12 | Microsoft halten | Der Aktionär | |
09.03.12 | Linde kaufen | Bankhaus Lampe KG | |
09.03.12 | Linde halten | National-Bank AG | |
09.03.12 | Apple outperform | Exane-BNP Paribas SA | |
09.03.12 | Texas Instruments outperform | RBC Capital Markets | |
09.03.12 | American Express underperform | RBC Capital Markets | |
09.03.12 | Apple outperform | RBC Capital Markets | |
09.03.12 | Honeywell outperform | RBC Capital Markets | |
08.03.12 | Apple buy | Deutsche Bank Securities | |
08.03.12 | Apple overweight | Morgan Stanley | |
08.03.12 | American International Group (AIG) neutral | UBS AG | |
08.03.12 | Apple buy | UBS AG | |
08.03.12 | FedEx overweight | Barclays Capital | |
08.03.12 | Intel buy | UBS AG | |
07.03.12 | Apple overweight | Barclays Capital | |
07.03.12 | AMD (Advanced Micro Devices) equal-weight | Barclays Capital | |
07.03.12 | Apple overweight | Barclays Capital | |
07.03.12 | American Express equal-weight | Barclays Capital | |
07.03.12 | Lockheed Martin outperform | RBC Capital Markets | |
06.03.12 | Linde buy | UBS AG | |
06.03.12 | ConocoPhillips sell | UBS AG | |
06.03.12 | Halliburton outperform | RBC Capital Markets | |
05.03.12 | Coca-Cola neutral | UBS AG | |
05.03.12 | Linde halten | Independent Research GmbH | |
05.03.12 | American International Group (AIG) neutral | UBS AG | |
05.03.12 | Target buy | UBS AG | |
05.03.12 | Linde halten | Norddeutsche Landesbank (Nord/LB) | |
05.03.12 | Johnson Johnson kaufen | Die Actien-Börse | |
02.03.12 | Tesla kaufen | Fuchsbriefe | |
02.03.12 | Caterpillar buy | Sarasin Research | |
01.03.12 | ExxonMobil buy | UBS AG | |
01.03.12 | Abbott Laboratories buy | UBS AG | |
01.03.12 | Visa neutral | UBS AG |